All
Our healthcare organization has designated “population health management” as a core part of our strategy planning and accountability. This is reflected through the implementation of what is defined as the “quadruple aim:” –providing health care which is affordable,... more
The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy. After reviewing recent... more
It is with great pleasure that we bring you this issue focusing on Clinical Conundrums in Special Populations. As Dr. Ito mentions in his Presidents Message the NLA has been very busy this year. In an effort to help clinical lipidologists we convened a panel of Clinical Lipidology experts to... more
Please review the entire page to register for this activity. Release Date: February 18, 2015 Expiration Date: March 18, 2015 Program Format: Internet Live Multimedia Fee There is no fee associated with this activity. Hosted by the Pacific Lipid Association Program Overview... more
JACKSONVILLE, Fla. -- The National Lipid Association announced Monday it has united with MD Magazine®, a leading online and print source of physician news, conference coverage, and peer-to-peer discussion, through Michael J. Hennessy Associates' Strategic Alliance Partnership (SAP) Program... more
The National Lipid Association along with a panel of outside experts from various disciplines convened for a workshop in late July to examine how health information technology (HIT) can be used, to effectively improve LDL-C goal attainment. Read more here.
It is my great honor to serve as President of the Northeast Lipid Association (NELA). One of the responsibilities of the President is to choose the topics and invite the authors for Lipid Spin. Accordingly, this edition of Lipid Spin was developed with my suggestions and direct input. I must say... more
What are some of the causes of high triglycerides? What is the biggest health risk? And, for these patients, at what level is the risk greater for developing pancreatitis and coronary artery disease? Host Dr. Alan Brown welcomes Dr. Carl Orringer, Associate Professor of Medicine at the Cardiology... more
Leveraging the Power of Coronary CTA to Guide Primary Prevention Treatment in ASCVD Presented by Dinesh Kalra, MD, FNLA October 10, 2024 Risk of Dementia Presented by Benjamin Hirsh, MD, FNLA & Tia Bimal, MD... more
On behalf of the National Lipid Association, the 2020 Annual Business Meeting will be held electronically Monday, June 8, 2020 from 6:00-6:30 PM ET.


.png)







